Source: Eur Respir J 2016; 47: 31-34



Rating:

Share or cite this content

Citations should be made in the following way:
Hughes J. Michael B.. Hypoxic pulmonary vasoconstriction: clinical implications. Eur Respir J 2016; 47: 31-34

Member's Comments

No comment yet.

Related content which might interest you: Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that? Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017 Year: 2017 Dag-dependent regulation of trpc6 in hypoxic pulmonary vasoconstriction Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Hypoxic pulmonary vasoconstriction (HPV) - basic mechanisms Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 Effects of hypobaric hypoxia on circulating microRNA expression and hypoxic pulmonary vasoconstriction Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Effects of Sildenafil on hypoxic pulmonary vasoconstriction in dogs Source: Eur Respir J 2001; 18: Suppl. 33, 490s Year: 2001 Perfusion abnormalities related to hypoxic vasoconstriction in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 266s Year: 2002 Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Acute vasodilator response in different forms of pre-capillary pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms Source: Eur Respir J 2008; 32: 1639-1651 Year: 2008 Contributions of TRPV4 to altered pulmonary vasoreactivity in mice with pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms Source: Eur Respir J, 51 (5) 1800816; 10.1183/13993003.00816-2018 Year: 2018 Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer? Source: Eur Respir J 2009; 33: 1247-1249 Year: 2009 Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017